We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
-5.72%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.62B
AUM Growth
-$87M
Cap. Flow
+$163M
Cap. Flow %
6.23%
Top 10 Hldgs %
19.04%
Holding
306
New
25
Increased
130
Reduced
75
Closed
44

Top Buys

Rank Stock Value
1
FOUR icon
Shift4
FOUR
+$21.9M
2
MTDR icon
Matador Resources
MTDR
+$20.5M
3
PCRX icon
Pacira BioSciences
PCRX
+$20.3M
4
CRS icon
Carpenter Technology
CRS
+$15.7M
5
HAE icon
Haemonetics
HAE
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 22.67%
2 Healthcare 19.07%
3 Industrials 16.32%
4 Consumer Discretionary 15.92%
5 Financials 12.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARHS icon
101
Arhaus
ARHS
$1.09B
$7.92M 0.3%
930,901
+87,926
+10% +$731K
TMDX icon
102
Transmedics
TMDX
$2.56B
$7.57M 0.29%
280,953
+36,137
+15% +$647K
HASI icon
103
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.91B
$7.47M 0.28%
157,447
-5,114
-3% -$229K
CCNE icon
104
CNB Financial Corp
CCNE
$1.02B
$7.3M 0.28%
277,220
-8,806
-3% -$236K
MSFT icon
105
Microsoft
MSFT
$2.93T
$7.04M 0.27%
22,818
+1
+0% +$301
NDLS icon
106
Noodles & Co
NDLS
$65.5M
$6.84M 0.26%
143,286
+16,345
+13% +$1M
THRN
107
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$6.48M 0.25%
1,018,369
+325,339
+47% +$1.75M
OCUL icon
108
Ocular Therapeutix
OCUL
$1.96B
$6.39M 0.24%
1,291,905
+234,178
+22% +$1.3M
TLYS icon
109
Tilly's
TLYS
$121M
$6.33M 0.24%
675,729
+66,119
+11% +$815K
MASS icon
110
908 Devices
MASS
$302M
$6.26M 0.24%
329,442
+28,618
+10% +$492K
BW icon
111
Babcock & Wilcox
BW
$1.47B
$6.12M 0.23%
749,465
+47,242
+7% +$368K
PTLO icon
112
Portillo's
PTLO
$338M
$5.99M 0.23%
243,927
+24,097
+11% +$638K
TTI icon
113
TETRA Technologies
TTI
$1.37B
$5.84M 0.22%
1,420,343
+1,132,499
+393% +$3.62M
SSB icon
114
SouthState Bank Corp
SSB
$10.1B
$5.67M 0.22%
69,559
-90,359
-57% -$7.79M
CRIS icon
115
Curis
CRIS
$9.02M
$5.27M 0.2%
5,540
+512
+10% +$654K
NVDA icon
116
NVIDIA
NVDA
$4.91T
$4.5M 0.17%
165,010
+7,500
+5% +$188K
AMZN icon
117
Amazon
AMZN
$2.66T
$3.96M 0.15%
24,300
-1,120
-4% -$173K
GOOGL icon
118
Alphabet (Google) Class A
GOOGL
$4.23T
$3.71M 0.14%
26,640
GNRC icon
119
Generac Holdings
GNRC
$12.7B
$3.62M 0.14%
12,188
+2,471
+25% +$741K
HZNP
120
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.21M 0.12%
30,522
+1,083
+4% +$106K
ZVIA icon
121
Zevia
ZVIA
$122M
$2.94M 0.11%
643,707
+20,150
+3% +$140K
P
122
Everpure Inc
P
$23.1B
$2.65M 0.1%
75,148
-4,527
-6% -$132K
CVRX icon
123
CVRx
CVRX
$130M
$2.4M 0.09%
400,536
+33,320
+9% +$269K
ENFN
124
DELISTED
Enfusion, Inc.
ENFN
$2.39M 0.09%
187,913
+18,843
+11% +$288K
WSC icon
125
WillScot Mobile Mini Holdings
WSC
$4.93B
$2.26M 0.09%
57,798
+6,274
+12% +$236K

Similar funds

Emerald Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, Emerald Advisers held 306 positions worth $2.62B, down 3.2% from $2.71B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Emerald Advisers deployed $163M of net new capital in Q1 2022, opening 25 new positions and adding to 130 existing holdings. Its largest new stake was Shift4: 415,980 shares worth $25.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Eastern Bankshares, an estimated $31.5M trimmed.

  • Emerald Advisers's largest Q1 2022 buy was Shift4: 415,980 shares worth $25.8M.
  • Emerald Advisers added most to Carpenter Technology in Q1 2022, an estimated $15.7M increase.
  • Emerald Advisers's biggest Q1 2022 reduction was Eastern Bankshares, cutting an estimated $31.5M.
  • Emerald Advisers fully exited Cohu in Q1 2022, selling an estimated $20.4M.
  • Emerald Advisers's ten largest holdings make up 19% of its $2.62B portfolio in Q1 2022.
  • Emerald Advisers opened 25 new positions and closed 44 in Q1 2022.
  • Emerald Advisers's portfolio value fell 3.2% quarter-over-quarter to $2.62B.

Based on Emerald Advisers's 13F filing for Q1 2022, filed 29 Apr 2022.